Tardio Jason — SEC Form 4 filings
SEC reporting owner CIK 1794698. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-26 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 25,024 shares, $19,769 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 12,512 shares @ $0.79 ($9,884) in IMMUNIC, INC., filed 2025-06-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IMMUNIC, INC. (IMUX) | President and COO | 6 | 2 legs · 25,024 sh · $19,769 | — | 10 |
| Ovid Therapeutics Inc. (OVID) | Chief Operating Officer | 1 | — | — | 2 |
Form 4 filings — Tardio Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 253,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 330,000 (derivative) @ $0 · Grant/award (A): 660,000 (derivative) @ $0 · Grant/award (A): 660,000 (derivative) @ $0 · Grant/award (A): 330,000 (derivative) @ $0 · Grant/award (A): 330,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4/A | IMMUNIC, INC. (IMUX) | Purchase (P): 12,512 @ $0.79 · Grant/award (A): 598,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | IMMUNIC, INC. (IMUX) | Purchase (P): 12,512 @ $0.79 · Grant/award (A): 595,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 157,500 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | Ovid Therapeutics Inc. (OVID) | Grant/award (A): 28,125 @ $0 · Grant/award (A): 168,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1794698 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →